Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001231919-26-000231

Director bought 300,000 shares at $16.00 ($4,800,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2026-02-26 Purchase +300,000 $16.00 $4,800,000 4,603,418 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2026-02-26 Purchase · Pre-Funded Warrant (Right to Buy) +2,200,000 $16.00 $35,199,780 2,200,000 I
Open-market purchases · 300,000 sh · avg $16.00 · $4,800,000
Loading xslF345X05/form4-03022026_090351.xml…